Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersInfectious Disease Physician in Baltimore, MD
NPI: 1023313632Primary Practice Location
JOHNS HOPKINS HOSPITAL, THE
1800 Orleans St, Baltimore, MD
Primary Employer
Jhu - Medicine/Infectious Disease
hopkinsmedicine.org
HQ Phone
Get M.D. Juhi's Phone Numberphone_androidMobile
Get M.D. Juhi's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
American Board of Internal Medicine
Infectious Disease
American Board of Internal Medicine
Internal Medicine
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 68 | 83 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 29 | 41 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 25 | 25 |
| 4 | 99231Subsequent hospital inpatient care, typically 15 minutes per day | 20 | 24 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 20 | 21 |
Authors: Mark Sulkowski, Sophie Lanzkron, Diana Brainard
Journal: Clin Infect Dis
Hepatitis C Elimination in People With HIV Is Contingent on Closing Gaps in the HIV Continuum.
Authors: Mark Sulkowski, Karla Perez-Goldberg
Journal: Open Forum Infect Dis
Publication Date: 2019-09-30
Authors: Mark Sulkowski
Journal: J Infect Dis
Lead Sponsor: University of Florida
Collaborators: AbbVie, Merck Sharp & Dohme LLC, Patient-Centered Outcomes Research Institute
Intervention / Treatment: DRUG: Ribavirin, DRUG: SOF/LDV (sofosbuvir/ledipasvir), DRUG: PrOD (ombitasvir/paritaprevir/ritonavir with dasabuvir) (Phase 1 only), DRUG: EBR/GZR (elbasvir/grazoprevir)
